Hormonal Therapy in Advanced Endometrial Cancer Hormonal Therapy in Advanced Endometrial Cancer
This meta-analysis may finally clarify which patients are most likely to respond to hormonal therapy.Medscape (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 15, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Artificial ovaries could replace hormone therapy
Researchers with the Wake Forest Institute for Regenerative Medicine have found that bioengineered ovaries are more effective than hormone therapy drugs at improving bone and uterine health.   The researchers are looking into the artificial ovaries as an alternative to hormone replacement medications, which work to help with the loss of female sex hormone production. Loss of ovarian function can affect the genital and urinary system, including urinary incontinence, among other issues.   The researchers… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 14, 2017 Category: Biotechnology Authors: Jessica Seaman Source Type: news

Wake Forest study: Lab-engineered ovaries could be better than hormone therapy
Researchers with the Wake Forest Institute for Regenerative Medicine have found that bioengineered ovaries are more effective than hormone therapy drugs at improving bone and uterine health, along with body composition in rats.   The researchers are looking into the artificial ovaries as an alternative to hormone replacement medications, which work to help with the loss of female sex hormone production. Loss of ovarian function can affect the genital and urinary system, including urinary incontinence,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 14, 2017 Category: Pharmaceuticals Authors: Jessica Seaman Source Type: news

USPSTF Finalizes Recommendations Against Hormone Therapy for Preventing Chronic Conditions
The U.S. Preventive Services Task Force has finalized its recommendations against hormone therapy for preventing chronic conditions in postmenopausal women. The grade D recommendations, published... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 14, 2017 Category: Primary Care Source Type: news

Will New Postmenopausal Hormone Therapy Recommendation Scare Off Women Who Need It For Hot Flashes?
Relatively few women use postmenopausal hormone therapy nowadays to stave off diseases as they age. So will a respected panel's new recommendation against its use for that purpose lead to undertreatment of hot flashes and night sweats? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 13, 2017 Category: Pharmaceuticals Authors: Rita Rubin, Contributor Tags: NYSE:PFE Source Type: news

Will Postmenopausal Hormone Therapy Recommendation Scare Off Women Who Need It For Hot Flashes?
Relatively few women use postmenopausal hormone therapy nowadays to stave off diseases as they age. So will a respected panel's new recommendation against its use for that purpose lead to undertreatment of hot flashes and night sweats? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 13, 2017 Category: Pharmaceuticals Authors: Rita Rubin, Contributor Tags: NYSE:PFE Source Type: news

Older women should not take hormones to prevent chronic diseases
(Reuters Health) - Postmenopausal women should not use hormone therapy to prevent chronic medical conditions, because the risk of significant side effects outweighs the unclear evidence of a benefit, according to a government-backed panel of experts. (Source: Reuters: Health)
Source: Reuters: Health - December 12, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Makayla ’s story: Living with Leri-Weill Dyschondrosteosis
Our daughter Makayla was born perfectly healthy on April 5th, 2014, passing all of the usual newborn screenings without issue. From day one, her personality shone through. She was strong-willed and had a smile that would light up her eyes before her mouth even showed a hint of joy. But over the next 3 months, Makayla wasn’t eating well and wasn’t gaining enough weight.  Our pediatrician referred us to Dr. Elizabeth Hait, a gastroenterologist at Boston Children’s Hospital. Dr. Hait would change Makayla’s formula multiple times and put her on medication for her acid reflux. Her pediatrician also ...
Source: Thrive, Children's Hospital Boston - December 12, 2017 Category: Pediatrics Authors: Kerri Theriault Tags: Our Patients’ Stories Division of Endocrinology Dr. James Kasser Dr. Travis Matheney hip dysplasia Orthopedic Center Otolaryngology Department Source Type: news

Fewer Hormonal Meds for Breast Cancer Patients?
Women with earlier-stage breast cancer may be able to spend less time on hormonal therapy without dimming their prognosis, a new study suggests. (Source: WebMD Health)
Source: WebMD Health - December 8, 2017 Category: Consumer Health News Source Type: news

For Breast Cancer Patients, Less Time on Hormonal Meds?
THURSDAY, Dec. 7, 2017 -- Women with earlier-stage breast cancer may be able to spend less time on hormonal therapy without dimming their prognosis, a new study suggests. In a trial of nearly 3,500 patients, researchers found that seven years of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 7, 2017 Category: General Medicine Source Type: news

Thyroid hormone therapy heals lung fibrosis in animal study
In addition to a promising new treatment for the deadly lung disease, the new research offers unexpected insight into how fibrosis works on a cellular level. (Source: Yale Science and Health News)
Source: Yale Science and Health News - December 4, 2017 Category: Universities & Medical Training Source Type: news

Breast cancer patients don't trust the system and want better treatment, according to new study
(Natural News) A growing number of breast cancer patients are beginning to trust their own instincts and go against their doctor’s advice. In a new survey, nearly one third of women with breast cancer chose to forgo the full, recommended course of chemotherapy, radiation, or hormone therapy, post-surgery. Health authorities find this troubling because “treatment... (Source: NaturalNews.com)
Source: NaturalNews.com - December 1, 2017 Category: Consumer Health News Source Type: news

Hormone therapy after menopause not linked to stroke risk
Women who undergo hormone therapy after menopause are not at higher risk of stroke, research published in the journalPLOS Medicine suggests.Psych Central (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 27, 2017 Category: Endocrinology Source Type: news

Risk of breast cancer recurrence lasts for decades
(Reuters Health) - Many women who follow initial breast cancer treatment with five years of hormone therapy to keep tumors at bay may still experience new malignancies up to two decades after their diagnosis, a study suggests. (Source: Reuters: Health)
Source: Reuters: Health - November 17, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Stopping HRT after menopause may increase cardiovascular disease risk
Research published inMenopause reports that women who stop hormone therapy after menopause are at higher risk of cardiac and stroke death.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 17, 2017 Category: Endocrinology Source Type: news

CV Deaths in Younger Women Rise During Year After Stopping HT CV Deaths in Younger Women Rise During Year After Stopping HT
Women younger than 60 years had a higher risk for cardiac and stroke death during the first year after stopping hormone therapy compared with those not taking HT and those continuing HT, a study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 16, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Oncotarget: Researchers identify potential therapeutic target in aggressive breast cancer cells
(Rapamycin Press) An especially aggressive breast cancer cell can respond to hormone therapy if they express a specific protein known as estrogen receptor beta, according to research published in Oncotarget. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 15, 2017 Category: Cancer & Oncology Source Type: news

Risk of breast cancer recurring persists after end of hormone therapy
According to a study, published in theNew England Journal of Medicine, women successfully treated for breast cancer with hormone therapy still have an increased risk of it returning, even 15 years after hormone therapy ended.Newsweek  (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 10, 2017 Category: Endocrinology Source Type: news

Growth-hormone Therapy Does Not Raise Heart Risks in Adulthood Growth-hormone Therapy Does Not Raise Heart Risks in Adulthood
Growth-hormone treatment during childhood does not increase young adults ’ cardiovascular disease (CVD) risk, but it improves their lipid profiles, according to industry-funded research.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 9, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Breast cancer 'can return 15 years after treatment ends'
Extending treatment with hormone therapy could reduce the risk of it recurring. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 9, 2017 Category: Consumer Health News Source Type: news

Stopping hormone therapy increases risk of cardiac complications
According to a study, published inMenopause, discontinuing hormone therapy increases the risk of heart–related complications and stroke.News Medical (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 9, 2017 Category: Endocrinology Source Type: news

Risk of cardiac and stroke death increases after discontinuing hormone therapy
(The North American Menopause Society (NAMS)) Hormone therapy (HT) continues to be a hotly debated topic. The benefits of estrogen to the heart, however, appear to be universally accepted. A new study demonstrates that the risk of cardiac and stroke death actually increases in the first year after discontinuation of HT. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 8, 2017 Category: International Medicine & Public Health Source Type: news

Hormone Therapy for Menopausal Women in Primary Care Hormone Therapy for Menopausal Women in Primary Care
A better understanding of menopausal hormone therapy will help primary care providers adequately counsel and treat women suffering from vasomotor symptoms.Journal for Nurse Practitioners (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 6, 2017 Category: Consumer Health News Tags: Nursing Journal Article Source Type: news

Living With Cancer: Treating prostate cancer
Hormone therapy for prostate cancer? Most prostate cancer cells rely on testosterone to help them grow. Hormone therapy for prostate cancer, also called androgen deprivation therapy, is treatment to stop the male hormone testosterone from reaching prostate cancer cells in your body. Learn about how the therapy works, the possible side effects and risks, and [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 3, 2017 Category: Databases & Libraries Source Type: news

Women's Wellness: Hormone therapy and Alzheimer's disease
Introducing hormone treatment for women in early stages of menopause might help decrease their risk of dementia or Alzheimer's disease. For women, a drop in hormones during midlife may have some influence on developing dementia or Alzheimer's disease. Also, general brain volume gradually declines with advancing age, but the decline is faster in people who [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 2, 2017 Category: Databases & Libraries Source Type: news

Mayo Clinic researchers find genetic pathways to individualized treatment for advanced prostate cancer
ROCHESTER, Minn. ? Researchers at Mayo Clinic Center for Individualized Medicine have uncovered genetic clues to why tumors resist a specific therapy used for treating advanced prostate cancer. This discovery can guide health care providers to individualized treatments for castration-resistant prostate cancer, a deadly disease that does not respond to standard hormone therapy. Several U.S. [...] (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - November 1, 2017 Category: Research Source Type: news

Misconceptions About Hormone Therapy Persist Misconceptions About Hormone Therapy Persist
Many professionals in ob/gyn clinical practice reportedly lack understanding about hormone therapy and about data from the Women's Health Initiative trials, a study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 27, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Changing the Conversation About Hormone Therapy Changing the Conversation About Hormone Therapy
This brief report summarizes the 2017 Hormone Therapy Position Statement of The North American Menopause Society, which emphasizes an individualized, evidence-based approach.Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 26, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Is It Time to Rethink Hormone Therapy?
(MedPage Today) -- Study suggests risks may be overstated (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 23, 2017 Category: American Health Source Type: news

Medical News Today: Hormone therapy for prostate cancer increases cardiac risk
Androgen-deprivation therapy is widely used to treat prostate cancer. In a recent study, the potential risks to heart health are examined. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 18, 2017 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

' Change the Conversation' About Hormone Therapy in Menopause'Change the Conversation' About Hormone Therapy in Menopause
The North American Menopause Society's new position statement on hormone therapy is in the spotlight here at the 2017 annual meeting, where fears about treatment are being appeased.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 13, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

NAMS:'Take the Fear Out' of Hormone Therapy
(MedPage Today) -- JoAnn Pinkerton, MD, breaks down the highlights of NAMS updated position statement (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - October 13, 2017 Category: Endocrinology Source Type: news

Hormones may be safe migraine treatment for elderly
Hormone therapy may be safe and effective for treating migraine in the elderly, according to a study presented at the North American Menopause Society Annual Meeting.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 13, 2017 Category: Endocrinology Source Type: news

Life after cancer: “The real battle happened after treatment”
Bin McLaurin was lucky. Doctors detected his prostate cancer early, and he successfully completed the surgery, radiation and hormone therapy he needed to keep the disease at bay.But two years out from his 2014 diagnosis, McLaurin didn't feel so great. He had gained 60 pounds during treatment,... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - October 12, 2017 Category: Science Authors: Eryn Brown Source Type: news

Hormone Therapy May Be OK for Women With Migraines
Title: Hormone Therapy May Be OK for Women With MigrainesCategory: Health NewsCreated: 10/11/2017 12:00:00 AMLast Editorial Review: 10/12/2017 12:00:00 AM (Source: MedicineNet Migraine General)
Source: MedicineNet Migraine General - October 12, 2017 Category: Neurology Source Type: news

Hormone therapy may be OK for women with migraines
Women who suffer from migraines may be able to safely use hormone therapy to treat menopause symptoms, a new study suggests. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 12, 2017 Category: Consumer Health News Source Type: news

Hormone Therapy May Be OK for Women With Migraines
Heightened risk of stroke not borne out in preliminary study (Source: WebMD Health)
Source: WebMD Health - October 11, 2017 Category: Consumer Health News Source Type: news

Hormone Therapy May Be OK for Women With Migraines
WEDNESDAY, Oct. 11, 2017 -- Women who suffer from migraines may be able to safely use hormone therapy to treat menopause symptoms, a new study suggests. The study of 85,000 U.S. women found no evidence that hormone therapy carried a particular risk... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 11, 2017 Category: General Medicine Source Type: news

Despite effectiveness women remain skeptical of hormones at menopause -- what's the problem?
(The North American Menopause Society (NAMS)) Women today have more options than ever before for treating their menopause symptoms, although hormone therapy still ranks as the most effective treatment for debilitating symptoms such as hot flashes. A new study demonstrates, however, that women remain skeptical regarding the safety of hormone therapy and prefer less proven options. The study results will be presented during The North American Menopause Society (NAMS) Annual Meeting in Philadelphia, Oct. 11-14. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - October 11, 2017 Category: International Medicine & Public Health Source Type: news

Health Canada accepts marketing application for Mithra ’s hormone therapy Tibelia
Health Canada has accepted a marketing authorisation application for the Belgian pharmaceutical company Mithra ’s complex therapeutic Tibelia, a tibolone-based product, to be used in hormone therapy (HT). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 11, 2017 Category: Pharmaceuticals Source Type: news

Hormone Therapy and Technology Headline NAMS Meeting Hormone Therapy and Technology Headline NAMS Meeting
The theme of technology will run through the North American Menopause Society (NAMS) meeting, but hormone therapy, breast imaging, lesbian health, and vaginal health are also on the agenda.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 5, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Transgender Hockey Player Postpones Hormone Treatment To Keep Playing
Sports leagues have struggled with how to define gender when it comes to deciding who can play. Pro hockey player Harrison Browne has decided to postpone hormone therapy for one more year on the ice.(Image credit: Courtesy of the National Women's Hockey League) (Source: NPR Health and Science)
Source: NPR Health and Science - September 24, 2017 Category: Consumer Health News Authors: Maggie Mertens Source Type: news

PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include hospital factors relevant to readmission, hormone therapy, lymph node dissection in breast cancer, and the cost of bringing a new drug to market (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - September 16, 2017 Category: American Health Source Type: news

Diabetes Drugs' CV Effects; Hormone Therapy; Aneurysms Reduced with T2D?
(MedPage Today) -- Cardiovascular Daily wraps up the top cardiology news of the week (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 15, 2017 Category: Cardiology Source Type: news

Menopause hormone therapy not linked to premature death
According to a study published inJAMA, women who take hormone replacement therapy may be no more likely to die prematurely than women who do not take hormones.Reuters  (Source: Society for Endocrinology)
Source: Society for Endocrinology - September 14, 2017 Category: Endocrinology Source Type: news

Hormone Therapy Isn't As Risky As Once Thought, New Study Finds
Good news for menopausal women. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - September 14, 2017 Category: Consumer Health News Source Type: news

Hormone Therapy Isn't As Risky As Once Thought, New Study Finds
Good news for menopausal women. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - September 14, 2017 Category: Consumer Health News Source Type: news

Could hormone therapy for menopause make a comeback?
New research suggests the hormone therapy won't increase risk of early death (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - September 13, 2017 Category: Consumer Health News Source Type: news

Diabetes Targets Hard to Meet in Transgender Population
(MedPage Today) -- Hormone therapy tied to increased modi?able risks (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - September 13, 2017 Category: Primary Care Source Type: news